Cargando…

Tenofovir use is associated with low vitamin D levels in a Spanish HIV cohort

Detalles Bibliográficos
Autores principales:	Cervero, M, García Lacalle, C, Agud, JL, Perea, R Torres, García-Benaya, E, Jusdado, J, Pons, C Pérez, del Álamo, M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The International AIDS Society 2010
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112878/ http://dx.doi.org/10.1186/1758-2652-13-S4-P104

Ejemplares similares

Prevalence of vitamin D deficiency: cross-sectional study of a hospital cohort of HIV-1 infected outpatients
por: Cervero, M, et al.
Publicado: (2010)

Prevalence of and risk factors for low bone mineral density in Spanish treated HIV-infected patients
por: Cervero, Miguel, et al.
Publicado: (2018)

Nutritional status in HIV-infected patients using Changi's mini nutritional assessment
por: Cervero, M, et al.
Publicado: (2010)

Lack of utility of phosphate serum monitoring in HIV-infected patients on a tenofovir-based antiretroviral regimen
por: Wikman, P, et al.
Publicado: (2010)

Lopinavir/ritonavir monotherapy in clinical practice
por: Caso, A, et al.
Publicado: (2010)

Intracellular tenofovir-diphosphate accumulation in an HIV-infected patient with Fanconi syndrome and osteomalacia
por: Haverkort, ME, et al.
Publicado: (2010)

The AIRE gene and susceptibility to rheumatoid arthritis in the Spanish population
por: Torres, Belen, et al.
Publicado: (2011)

Role of platelet activation in the cardiovascular complications associated with HIV infection: differential effect of abacavir versus tenofovir
por: Francisci, D, et al.
Publicado: (2010)

Kidney tubular function and serum phosphate levels in HIV-1-infected patients treated with tenofovir: preliminary results
por: Grima, P, et al.
Publicado: (2010)

Clinical and genetic features of Spanish patients with Mevalonate kinase deficiency
por: Ruiz-Ortiz, E, et al.
Publicado: (2015)

Prevalence of cardiovascular risk factors in Spanish HIV-1-infected male inmates
por: Golf, JP, et al.
Publicado: (2010)

Infrequent, low magnitude HIV-specific T cell responses in HIV-uninfected participants in the 1% tenofovir microbicide gel trial (CAPRISA004)
por: Burgers, WA, et al.
Publicado: (2012)

Efficacy of an information system addressed to nursing staff for diminishing contaminated blood cultures: a blind clinical trial
por: Cervero, Miguel, et al.
Publicado: (2019)

Response to treatment of hepatitis C in HCV/HIV co-infected patients is not influenced by either abacavir or tenofovir with weight-based ribavirin
por: Bhatti, L, et al.
Publicado: (2010)

HRQoL improves in treatment-naïve HIV-1 subjects initiated on lopinavir/ritonavir (LPV/r) with raltegravir (RAL) or tenofovir/emtricitabine (TDF/FTC)
por: Baran, RW, et al.
Publicado: (2010)

Spanish validation of Bad Sobernheim Scoliosis Questionnaire for adolescents wearing braces
por: Alomar, E, et al.
Publicado: (2009)

National rare diseases registry in Spain: pilot study of the Spanish Rare Diseases Registries Research Network (SpainRDR)
por: Alonso, Verónica, et al.
Publicado: (2014)

P17-07. Insertion of a vaccinia virus host range (hr) gene into NYVAC-B genome potentiates immune responses against HIV-1 antigens
por: Najera, JL, et al.
Publicado: (2009)

Cost-efficacy analysis of the MONET trial using Spanish antiretroviral drug prices
por: Arribas, JR, et al.
Publicado: (2010)

Staphylococcus aureus bacteremia in a secondary level Spanish hospital: clinical implications of high vancomycin MIC
por: Abelenda Alonso, Gabriela, et al.
Publicado: (2018)

Geographic variation in the reversal of vitamin K antagonist-associated coagulopathy
por: Neal, M, et al.
Publicado: (2008)

Designing a cardiac surgery mortality risk model with spanish population
por: Pérez Cheng, M, et al.
Publicado: (2015)

Icu and long-term mortality analisis of hematology patients admitted in icu. a 7 years review from a single spanish center
por: Garcia Gigorro, R, et al.
Publicado: (2015)

Spanish trauma icu registry (RETRAUCI). final results of the pilot phase
por: Chico-Fernández, M, et al.
Publicado: (2015)

Vitamin D and HIV: implications for chronic disease management
por: Dyner, Toby, et al.
Publicado: (2010)

Epidemiology and outcome of patients with severe sepsis in six Spanish ICUs
por: Lorente, L, et al.
Publicado: (2009)

HLA and non-HLA genes in Behçet’s disease: a multicentric study in the Spanish population
por: Montes-Cano, Marco Antonio, et al.
Publicado: (2012)

Risk factors of contrast-associated acute kidneyinjury in spanish intensive care patients: preliminary results of the nefrocon study
por: Mas-Font, S, et al.
Publicado: (2015)

Toxic intracellular anabolite levels of tenofovir and didanosine causing a steep CD4-cell decline
por: de Jong, E, et al.
Publicado: (2010)

Comparison of cerebral hemodynamic variables in hemorrhagic stroke using dexmedetomidine–propofol versus dexmedetomidine–midazolam
por: Perez-Rada, FJ, et al.
Publicado: (2009)

Analysis of biologic therapy in rheumatoid arthritis in a southern Spanish hospital population
por: Uceda-Montañés, J, et al.
Publicado: (2010)

5-year safety and efficacy of the once-daily antiretroviral regimen of efavirenz (EFV)/emtricitabine (FTC)/tenofovir disoproxil fumarate (TDF)
por: Lazzarin, A, et al.
Publicado: (2010)

Validation of the probability of survival using the triss methodology in the Spanish Trauma ICU registry (RETRAUCI)
por: Chico-Fernández, M, et al.
Publicado: (2015)

The 10 year safety and efficacy of tenofovir disoproxil fumarate (TDF)-containing once-daily highly active antiretroviral therapy (HAART)
por: Cassetti, I, et al.
Publicado: (2010)

Mutations in the Fas gene found in Spanish ALPS (autoimmune lymphoproliferative syndrome) patients
por: Martínez-Martínez, L, et al.
Publicado: (2010)

376. COVID-19 Severity in HIV+ Patients Receiving Tenofovir
por: Homsi, Nora, et al.
Publicado: (2020)

Vitamin D levels among HIV-infected patients – peculiar features
por: Chiriac, Carmen, et al.
Publicado: (2013)

PReS-FINAL-2115: Differences in musculoskeletal clinical expression between Spanish and Mexican patients with juvenile spondyloarthritis: data from the Mexespa project
por: Sifuentes Giraldo, WA, et al.
Publicado: (2013)

Nevirapine (NVP) vs ritonavir-boosted atazanavir (ATV/r) combined with tenofovir/emtricitabine (TDF/FTC) in first-line therapy: NEWART 48-week data
por: DeJesus, E, et al.
Publicado: (2010)

48 week bone marker changes with Dolutegravir (DTG) plus Abacavir/Lamivudine (ABC/3TC) vs. Tenofovir/Emtricitabine/Efavirenz (EFV/TDF/FTC): the SINGLE trial
por: Yazdanpanah, Y, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_rj2je0be9c4kffp6rfdrsvqdge